Amoxicillin is an antibiotic used to treat bacterial infections such as ear infections, strep throat, pneumonia, and urinary tract infections. It works by killing bacteria that cause these infections.[2] Amoxil is currently approved and in use across 81 indications[4].[1]
Amoxil is one of 697 small molecule programs targeting Helicobacter Pylori Infection. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Patents
Pipeline
Competition
309 competitors in COVID-19
Amoxil
Stivarga
Aimovig
Aldactone
Nexavar
Calciferol
Activella
Angiomax
Tricor
Precedex
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jan 1, 1982
AMOXIL
NDA NDA050542
Jan 1, 1982
AMOXIL
NDA NDA050460
Jan 1, 1982
AMOXIL
NDA NDA050459
Jul 10, 1998
AMOXIL
NDA NDA050754
Apr 15, 1999
AMOXIL
NDA NDA050761
Apr 15, 1999
AMOXIL
NDA NDA050760
Jan 23, 2008
MOXATAG
NDA NDA050813
Sources